January 2011 Issue
Production planning is hard enough, but when uncertainty peaks, the challenges are compounded.
Drug shortages kill patients every day, right here in the U.S. Its time for creative, market-based solutions.
For CEOs, maybe therapy comes with the territory.
Pharma Web Buzz: Johnson & Johnson rivaling Tiger Woods and BP in 2010 bad web press.
In an excerpt from an important new book, Pfizer's Claudio Denoya looks at alternative microbiological methods, and their connection with process analytical technology (PAT).
Six Sigma and OpEx now take a back seat to cost-cutting, yet experts say cost reduction will, ultimately, drive the industrys transformation
Saving money through outsourcing is really starting to cost us.
Reduce calibration costs and improve sensor integrity through statistical analysis in a validated environment.